高血压病史及血压水平对非瓣膜性房颤患者血栓栓塞风险的影响
基于中国房颤注册研究7 757例非瓣膜性房颤患者的前瞻性队列,平均随访35个月,455例(5.9%)发生血栓栓塞事件。高血压病史及收缩压≥140 mmHg是血栓栓塞的独立危险因素(HR分别为1.27和1.36),舒张压水平与风险无关。积极将收缩压控制在140 mmHg以下或可降低血栓栓塞风险。
要点
- 高血压病史使非瓣膜性房颤患者血栓栓塞风险独立增加27%(HR=1.27,95%CI 1.01–1.61)。
- 收缩压≥140 mmHg使血栓栓塞风险独立增加36%(HR=1.36,95%CI 1.02–1.82)。
- 收缩压120–139 mmHg及舒张压水平未显示与血栓栓塞风险独立相关。
核心结论
- 高血压病史及收缩压≥140 mmHg是非瓣膜性房颤患者发生血栓栓塞事件的独立危险因素。
- 积极将收缩压控制在140 mmHg以下或可降低此类患者的血栓栓塞风险。
研究设计与样本
- 中国心房颤动注册研究前瞻性纳入2011年8月至2018年12月北京市31家医院的房颤患者25 512例。
- 排除瓣膜性房颤、肥厚型心肌病及基线接受抗凝或导管消融治疗者后,最终纳入7 757例非瓣膜性房颤患者进行分析。
- 主要终点为首次发生缺血性卒中或系统性栓塞,采用多因素Cox回归模型分析高血压病史及血压水平与血栓栓塞的关联。
主要发现
- 平均随访(35±25)个月,455例(5.9%)发生血栓栓塞事件。
- 有高血压病史者血栓栓塞粗发生率为2.38/100人年,高于无高血压病史者的1.35/100人年(χ²=16.8,Log-rank P<0.001)。
- 基线收缩压<120、120–129、130–139和≥140 mmHg组血栓栓塞发生率分别为1.44、1.79、2.16和2.52/100人年(χ²=17.9,Log-rank P<0.001)。
- 基线舒张压<70、70–79、80–89和≥90 mmHg组血栓栓塞发生率差异无统计学意义(χ²=0.6,Log-rank P=0.907)。
- 多因素Cox回归显示高血压病史(HR=1.27,95%CI 1.01–1.61,P=0.045)和收缩压≥140 mmHg(HR=1.36,95%CI 1.02–1.82,P=0.036)为独立危险因素。
关键数值与推荐
- 高血压病史:校正CHA2DS2-VASc评分中除高血压以外因素后HR=1.28(95%CI 1.01–1.62,P=0.040);进一步校正房颤类型及抗血小板、他汀类药物后HR=1.27(95%CI 1.01–1.61,P=0.045)。
- 收缩压≥140 mmHg:校正CHA2DS2-VASc评分中除高血压以外因素后HR=1.37(95%CI 1.02–1.82,P=0.035);进一步校正房颤类型及抗血小板、他汀类药物后HR=1.36(95%CI 1.02–1.82,P=0.036)。
- 收缩压120–129 mmHg与<120 mmHg相比:HR=1.23(95%CI 0.90–1.67,P=0.193);收缩压130–139 mmHg与<120 mmHg相比:HR=1.30(95%CI 0.95–1.77,P=0.098)。
- 舒张压水平不是非瓣膜性房颤患者血栓栓塞事件的独立危险因素(P均>0.05)。
临床怎么用
- 对非瓣膜性房颤患者应评估高血压病史及基线收缩压水平,以辅助识别血栓栓塞高危人群。
- 对收缩压≥140 mmHg的非瓣膜性房颤患者,积极降压使收缩压低于140 mmHg可能有助于降低血栓栓塞风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the impact of history of hypertension and blood pressure levels on the thromboembolism risk in the setting of nonvalvular atrial fibrillation (NVAF). Methods: China Atrial Fibrillation Registry Study prospectively enrolled 25 512 atrial fibrillation (AF) patients between August 2011 and December 2018. After exclusion of patients with valvular AF, hypertrophic cardiomyopathy, receiving anticoagulation or ablation therapy at the enrollment, 7 757 patients were included in analysis. The primary endpoint was the time to the first occurrence of ischemic stroke or systemic embolism. Cox proportional hazards models were performed to evaluate whether a history of hypertension or blood pressure levels were independently associated with thromboembolism. Results: During a mean follow up of (35±25) months, 455 (5.9%)thromboembolic events occurred. The crude incidence rate of thromboembolism in patients with a history of hypertension was higher than that in patients without hypertension (2.38 vs. 1.35 per 100 patient-years, χ²=16.8,Log-rank P<0.001). Patients were further divided into 4 groups according to systolic blood pressure (SBP) levels at baseline, the crude incidence rate of thromboembolism significantly increased in proportion to the elevation of SBP levels (χ²=17.9,Log-rank P<0.001). However, there was no significant difference in thromboembolism risk among 4 groups stratified by diastolic blood pressure (DBP) levels (χ²=0.6,Log-rank P=0.907). Multivariable regression analysis showed that history of hypertension was independently associated with a 27% higher risk of thromboembolism (HR=1.27, 95%CI 1.01-1.61, P=0.045). Patients with SBP≥140 mmHg (1 mmHg=0.133 kPa) was associated with 36% higher risk of thromboembolism than patients with SBP<120 mmHg (HR=1.36, 95%CI 1.02-1.82, P=0.036). However, patients with SBP 120-129 mmHg or 130-139 mmHg were not at a higher risk of thromboembolism as compared to the patients with SBP<120 mmHg (SBP 120-129 mmHg: HR=1.23, 95%CI 0.90-1.67, P=0.193; SBP 130-139 mmHg: HR=1.30, 95%CI 0.95-1.77, P=0.098). In addition, DBP levels were not independently associated with the increased thromboembolism risk. Conclusion: A history of hypertension and SBP≥140 mmHg are independent predictors of thromboembolism risk in patients with NVAF. These results indicate that intensive efforts to lower SBP below 140 mmHg might be an important strategy to reduce the risk of stroke in patients with NVAF. 目的: 探讨高血压病史及血压水平对非瓣膜性心房颤动(NVAF)患者血栓栓塞事件的影响。 方法: 该研究的病例来自中国心房颤动注册研究,2011年8月至2018年12月于北京市31家医院前瞻性纳入了心房颤动(房颤)患者25 512例。排除瓣膜性房颤、肥厚型心肌病、基线接受抗凝或导管消融治疗的患者后,最终该研究纳入患者7 757例。随访终点为血栓栓塞事件,包括缺血性卒中和系统性栓塞。采用多因素Cox回归模型分析高血压病史、血压水平是否为NVAF患者发生血栓栓塞事件的独立危险因素。 结果: 研究随访(35±25)个月,随访结束时455例(5.9%)患者发生血栓栓塞事件。有高血压病史的NVAF患者血栓栓塞事件发生率高于无高血压病史的NVAF患者(2.38/100人年比1.35/100人年,χ²=16.8,Log-rank P<0.001)。基线收缩压<120 mmHg(1 mmHg=0.133 kPa)(n=1 619)、120~129 mmHg(n=2 023)、130~139 mmHg(n=1 728)和≥140 mmHg(n=2 172)的NVAF患者栓塞事件发生率依次升高,分别为1.44/100人年、1.79/100人年、2.16/100人年和2.52/100人年(χ²=17.9,Log-rank P<0.001)。基线舒张压<70 mmHg(n=1 128)、70~79 mmHg(n=2 277)、80~89 mmHg(n=2 804)和≥90 mmHg(n=1 328)的NVAF患者栓塞事件发生率差异无统计学意义(χ²=0.6,Log-rank P=0.907)。多因素Cox回归分析结果显示,校正了CHA2DS2-VASc评分中除高血压以外的因素后,高血压病史是NVAF患者发生血栓栓塞事件的独立危险因素(HR=1.28,95%CI 1.01~1.62,P=0.040);进一步校正了房颤类型以及使用抗血小板药物、他汀类药物后,高血压病史仍然是NVAF患者发生血栓栓塞事件的独立危险因素(HR=1.27,95%CI 1.01~1.61,P=0.045)。校正了CHA2DS2-VASc评分中除高血压以外的因素后,收缩压≥140 mmHg是NVAF患者发生血栓栓塞事件的独立危险因素(HR=1.37,95%CI 1.02~1.82,P=0.035);进一步校正了房颤类型以及使用抗血小板药物、他汀类药物后,收缩压≥140 mmHg仍然是NVAF患者发生血栓栓塞事件的独立危险因素(HR=1.36,95%CI 1.02~1.82,P=0.036);而收缩压120~129 mmHg和130~139 mmHg不是NVAF患者发生血栓栓塞事件的危险因素(分别为,HR=1.23,95%CI 0.90~1.67,P=0.193;HR=1.30,95%CI 0.95~1.77,P=0.098)。舒张压不是NVAF患者发生血栓栓塞事件的危险因素(P均>0.05)。 结论: 高血压病史及收缩压≥140 mmHg是NVAF患者发生血栓栓塞事件的独立危险因素,积极地将收缩压控制在140 mmHg以下或可降低此类患者的血栓栓塞风险。.
引用
- Zhu HJ, Jiang C, Kong XY, et al. [Impact of history of hypertension and blood pressure levels on the risk of thromboembolism in nonvalvular atrial fibrillation patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32957753. doi:10.3760/cma.j.cn112148-20200713-00552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。